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Since the European ban on prophylactic antibiotics, efforts are ongoing to identify suitable 
alternatives. β-glucans are potential candidates as upon oral administration these 
carbohydrate polymers protected piglets from an experimental infection with enterotoxigenic 
E. coli. To further fine-tune the rational design of β-glucans as nutraceuticals, we aimed to 
eludicate the receptors involved in the β-glucan-mediated immunomodulation in pigs. Several 
receptors, such as dectin-1 and complement receptor 3 (CR3), are reported to bind β-
glucans, however the contribution of these receptors in the response of innate immune cells 
towards β-glucans is still unresolved. Here, we report the crucial role of CR3 in β-glucan 
recognition by porcine neutrophils, as blocking this receptor strongly reduced the 
phagocytosis of β-glucans and the β-glucan-induced production of reactive oxygen species 
(ROS). However, in macrophages both dectin-1 and CR3 were involved in ROS production 
triggered by β-glucans, implying that receptor usage to recognize β-glucans is cell type-
specific. Moreover, we found that β-glucan receptor engagement on neutrophils and 
macrophages triggers a signalling cascade, which depended on focal adhesion kinase (FAK) 
to elicit ROS production, while Syk kinase was only partially involved in this process. In 
conclusion, CR3 plays a cardinal role in β-glucan recognition by porcine neutrophils, while 
macrophages use a more diverse receptor array to respond to β-glucans. Irrespective of the 
engaged receptors, the β-glucan-triggered signalling pathway is regulated by the master 
switch FAK in both cell types. Our findings could accelerate the implementation of β-glucans 
as nutraceuticals in the swine production industry. 
 
 
 
 
 
